The shares of Fertilizer company, specializing in providing agricultural solutions, including fertilizers, crop protection products, and bio-products, are in focus following the Bulk Deal involving BNP Paribas Financial Market.
With a market capitalization of Rs. 66,764.59 crores on Monday, the shares of Coromandel International Ltd declined by upto 1.5 percent, making a low of Rs. 2255.9 per share compared to its previous closing price of Rs. 2290.00 per share.
Coromandel International Ltd experienced a bulk deal, in which BNP Paribas Financial Markets sold 23.12 lakh shares, which consist of 0.78 percent stake at Rs. 2287.85 apiece, on May 30, 2025, resulting in a total value of around Rs. 529 Crores.
Financials & Others
The company’s total revenue rose by 27.9 percent from Rs. 3,996.25 crore to Rs. 5,113.44 crore in Q4FY24-25. Meanwhile, Net profit rose from Rs. 160.31 crore to Rs. 579.67 crore during the same period. Book value per share increased to Rs. 377 from Rs. 320, and basic EPS rose to Rs. 19.7 from Rs. 5.45.
The company has a strong financial position with a low debt-to-equity ratio of 0.07, and has delivered solid returns, averaging 15.72 percent ROE and 21.39 percent ROCE over the past three years.
Coromandel International Ltd., part of the Murugappa Group, is one of India’s leading agri-solutions providers and the country’s largest private sector phosphatic fertilizer company. It manufactures fertilizers, crop protection products, specialty nutrients, and organic fertilizers, and also operates India’s largest agri-retail chain with over 900 outlets.
Coromandel International Ltd. is the second-largest seller of phosphatic fertilizers in India and the leading seller of single super phosphate (SSP) with a 15 percent market share. The company also holds about 40 percent share in unique grade fertilizer sales and has a strong presence in Andhra Pradesh and Telangana, two of India’s largest complex fertilizer markets.
Written by Sridhar J
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
